Risk-adapted stratification for optimally intensive treatment assignment of pediatric patients with non-Hodgkin lymphoma is an effective strategy in developing countries.

@article{Belgaumi2017RiskadaptedSF,
  title={Risk-adapted stratification for optimally intensive treatment assignment of pediatric patients with non-Hodgkin lymphoma is an effective strategy in developing countries.},
  author={Asim F. Belgaumi and Mohammed Anas and Khawar Sohail Siddiqui and Mohammed F Akhter and Amani A Al-Kofide},
  journal={Pediatric blood & cancer},
  year={2017},
  volume={64 6}
}
BACKGROUND Pediatric patients with non-Hodgkin lymphoma (NHL) in developing countries (DCs) present with greater tumor load even at lower stages and with comorbidities that impact therapy delivery. This causes toxic mortality with "standard" intensive protocols or recurrences with "gentler" treatment. OBJECTIVES We developed and evaluated a risk… CONTINUE READING